Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Gerdts

Showing results (211-220 of 262) with videos related to

Pageof 27
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 30, 2015
Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE StudyRichard B Devereux, Casper N Bang, Mary J Roman, et al.
American Journal of Hypertension|February 9, 2013
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE studyMarina De Marco, Eva Gerdts, Giuseppina Casalnuovo, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension StudyIngrid Os, Veronica Franco, Sverre E Kjeldsen, et al.
Journal of Clinical Periodontology|February 3, 2025
Prevalence of Periodontitis in a 70-Year-Old Population in Western Norway According to the ACES 2018 Classification Framework: A Cross-Sectional StudyHager R Zein Elabdeen, Ellen Berggreen, Knut Helge Jensen, et al.
The American Journal of Cardiology|January 26, 2002
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)Jonathan N Bella, Kristian Wachtell, Kurt Boman, et al.
Heart (British Cardiac Society)|December 14, 2011
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosisIngar Holme, Terje R Pedersen, Kurt Boman, et al.
Blood Pressure|May 5, 2010
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE StudyKristian Wachtell, Eva Gerdts, Gerard P Aurigemma, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 1, 2020
Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Costantino Mancusi, Giovanni de Simone, Jana Brguljan Hitij, et al.
International Journal of Cardiology|October 15, 2011
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis studyAnders M Greve, Eva Gerdts, Kurt Boman, et al.
Circulation|March 15, 2006
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension StudyPeter M Okin, Richard B Devereux, Eva Gerdts, et al.
Pageof 27

Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|September 30, 2015
Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE StudyRichard B Devereux, Casper N Bang, Mary J Roman, et al.
American Journal of Hypertension|February 9, 2013
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE studyMarina De Marco, Eva Gerdts, Giuseppina Casalnuovo, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension StudyIngrid Os, Veronica Franco, Sverre E Kjeldsen, et al.
Journal of Clinical Periodontology|February 3, 2025
Prevalence of Periodontitis in a 70-Year-Old Population in Western Norway According to the ACES 2018 Classification Framework: A Cross-Sectional StudyHager R Zein Elabdeen, Ellen Berggreen, Knut Helge Jensen, et al.
The American Journal of Cardiology|January 26, 2002
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)Jonathan N Bella, Kristian Wachtell, Kurt Boman, et al.
Heart (British Cardiac Society)|December 14, 2011
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosisIngar Holme, Terje R Pedersen, Kurt Boman, et al.
Blood Pressure|May 5, 2010
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE StudyKristian Wachtell, Eva Gerdts, Gerard P Aurigemma, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 1, 2020
Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Costantino Mancusi, Giovanni de Simone, Jana Brguljan Hitij, et al.
International Journal of Cardiology|October 15, 2011
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis studyAnders M Greve, Eva Gerdts, Kurt Boman, et al.
Circulation|March 15, 2006
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension StudyPeter M Okin, Richard B Devereux, Eva Gerdts, et al.
Pageof 27